Therapeutic Solutions International Inc (TSOI)

[centsability4me]

TSOI CTE Formulas

for those of you following the TSOI CTE trail , there are 2 NeuroStilbene intra-nasal delivered products now.

One of these products is glioma/cancer therapeutics-related ,

Therapeutic Solutions International, Inc., Releases Intranasal Formulation of Pterostilbene for
Rapid Access to Blood-Brain Barrier
http://ih.advfn.com/p.php?pid=nmona&article=77868683

Late last year we filed a patent on the synergistic inhibition of glioma using pterostilbene. Our data suggest that when pterostilbene is combined with brain cancer therapeutics such as Temozolomide, Sertraline, or Gefitinib, their prognosis is improved. Furthermore, we observed that pterostilbene causes an increase of immunogenicity in chemotherapy-treated cancer cells, providing heightened immunity to cancer cells that escaped chemotherapy, theoretically enhancing patient prognosis


We are working on integrating NeuroStilbene into various protocols that are currently in development in order to enhance therapeutic options to patients with dreaded conditions such as brain tumors and neurodegenerative diseases



and the other is optimized for CTE.

Therapeutic Solutions International Announces CTE Optimized NeuroStilbene Formulation
http://ih.advfn.com/p.php?pid=nmona&article=78538984

The optimized formulation developed, possesses an enhanced delivery ability and increased concentration of the active ingredient, pterostilbene

The new formulation utilizes nanoparticle technology, combined with proprietary chemistry to ensure optimal concentrations of the active agent are found in the central nervous system to prevent pathology associated with neuronal injury